Aberdeen Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $7.33M | Sell |
186,024
-10,857
| -6% | -$428K | 0.02% | 407 |
|
|
2017
Q1 | $6.17M | Sell |
196,881
-132,351
| -40% | -$4.15M | 0.02% | 425 |
|
|
2016
Q4 | $10.3M | Sell |
329,232
-319,941
| -49% | -$9.99M | 0.04% | 323 |
|
|
2016
Q3 | $26.1M | Sell |
649,173
-227,805
| -26% | -$9.15M | 0.09% | 176 |
|
|
2016
Q2 | $29.2M | Sell |
876,978
-61,509
| -7% | -$2.04M | 0.11% | 142 |
|
|
2016
Q1 | $27.6M | Sell |
938,487
-63,987
| -6% | -$1.88M | 0.1% | 142 |
|
|
2015
Q4 | $49.7M | Buy |
1,002,474
+8,808
| +0.9% | +$436K | 0.17% | 79 |
|
|
2015
Q3 | $23.5M | Sell |
993,666
-38,532
| -4% | -$913K | 0.08% | 143 |
|
|
2015
Q2 | $24.5M | Buy |
1,032,198
+108,000
| +12% | +$2.56M | 0.07% | 152 |
|
|
2015
Q1 | $21.9M | Buy |
924,198
+282,024
| +44% | +$6.7M | 0.06% | 165 |
|
|
2014
Q4 | $13.6M | Buy |
642,174
+378,624
| +144% | +$8.04M | 0.03% | 226 |
|
|
2014
Q3 | $4.49M | Buy |
263,550
+53,472
| +25% | +$911K | 0.01% | 451 |
|
|
2014
Q2 | $3.01M | Buy |
210,078
+138,678
| +194% | +$1.98M | 0.01% | 564 |
|
|
2014
Q1 | $883K | Sell |
71,400
-1,800
| -2% | -$22.3K | ﹤0.01% | 490 |
|
|
2013
Q4 | $796K | Hold |
73,200
| – | – | ﹤0.01% | 494 |
|
|
2013
Q3 | $850K | Sell |
73,200
-1,800
| -2% | -$20.9K | ﹤0.01% | 464 |
|
|
2013
Q2 | $840K | Buy |
+75,000
| New | +$840K | ﹤0.01% | 457 |
|